Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,700 people across 41 countries.

Company’s Keywords:

early phase clinical research, phase iiiii clinical research, rwelate phase clinical research, medical device & diagnostics, regulatory affairs, medical writing, clinical monitoring, clinical trial management, biostatistics & data sciences, drug safety & pharmacovigilance, quality assurance, central laboratories, bioanalytical laboratories, imaging, ecg core labs, oncology clinical development, nephrology clinical development, neuroscience clinical development, infectious disease clinical development, cardiovascular clinical development, metabolic & endocrine clinical development, rare disease clinical development, cell & gene therapy clinical development